Németi Balázs, Poór Miklós, Gregus Zoltán
Department of Pharmacology and Pharmacotherapy, Toxicology Section, University of Pécs, Medical School , Pécs, Hungary.
Chem Res Toxicol. 2015 Nov 16;28(11):2199-209. doi: 10.1021/acs.chemrestox.5b00368. Epub 2015 Nov 3.
Dimethylarsinic acid (DMAs(V)) is the major urinary metabolite of inorganic arsenic. The relatively atoxic DMAs(V) is reduced in the body to the much more toxic and thiol-reactive dimethylarsinous acid (DMAs(III)). Glutathione S-transferase omega 1 (GSTO1) can catalyze this toxification step; however, its role in the reduction of DMAs(V) in vivo or by tissue extracts is unclear. Therefore, we assessed the role of GSTO1 in the reduction of DMAs(V) to DMAs(III) by rat liver cytosol. The experiments revealed that glutathione (GSH) supported the cytosolic DMAs(V) reduction specifically and that GSH analogues and GSH conjugates, such as S-alkylglutathiones and S-(4-nitrophenacyl)glutathione (4-NPG; a GSTO1 specific substrate), inhibited the formation of DMAs(III). Observations in line with the view that GSTO1 catalyzes the cytosolic reduction of DMAs(V) include (i) findings pointing to the presence of a GSH-binding site on the DMAs(V)-reducing cytosolic enzyme, (ii) identical responsiveness of the DMAs(V)- and 4-NPG-reducing activities in rat liver cytosol to the GSTO1 specific inhibitors KT53 and chloromethylfluorescein diacetate, and (iii) perfect coelution of the two activities during affinity and anion exchange chromatography of cytosolic proteins. Other observations appear ambiguous as to the role of GSTO1 in the cytosolic reduction of DMAs(V). These include the different sensitivities of the DMAs(V)-reducing and GSTO1 activities to aurothioglucose, trivalent antimony, and zinc ions, as well as the preserved GSTO1 activity in cytosols whose DMAs(V)-reducing activity was lost due to spontaneous thiol oxidation. These disparate findings may be reconciled by assuming that GSTO1 catalyzes the reduction of both DMAs(V) and 4-NPG in rat liver cytosol; however, the enzyme employs different sites and/or mechanisms when reducing these substrates.
二甲基胂酸(DMAs(V))是无机砷的主要尿代谢产物。相对低毒的DMAs(V)在体内会被还原为毒性更强且能与硫醇反应的二甲基亚胂酸(DMAs(III))。谷胱甘肽S-转移酶ω1(GSTO1)可催化这一毒性转化步骤;然而,其在体内或组织提取物中对DMAs(V)还原作用的具体机制尚不清楚。因此,我们评估了GSTO1在大鼠肝细胞溶胶中将DMAs(V)还原为DMAs(III)过程中的作用。实验表明,谷胱甘肽(GSH)特异性地支持细胞溶胶中DMAs(V)的还原,而GSH类似物和GSH共轭物,如S-烷基谷胱甘肽和S-(4-硝基苯甲酰基)谷胱甘肽(4-NPG;一种GSTO1特异性底物),则抑制DMAs(III)的形成。支持GSTO1催化细胞溶胶中DMAs(V)还原这一观点的观察结果包括:(i)有研究表明在还原DMAs(V)的细胞溶胶酶上存在一个GSH结合位点;(ii)大鼠肝细胞溶胶中还原DMAs(V)和4-NPG的活性对GSTO1特异性抑制剂KT53和二醋酸氯甲基荧光素具有相同的反应性;(iii)在细胞溶胶蛋白的亲和色谱和阴离子交换色谱过程中,这两种活性完全共洗脱。关于GSTO1在细胞溶胶中还原DMAs(V)过程中的作用,其他观察结果似乎并不明确。这些观察结果包括还原DMAs(V)的活性和GSTO1活性对金硫葡糖、三价锑和锌离子的不同敏感性,以及细胞溶胶中GSTO1活性得以保留,但其还原DMAs(V)的活性因自发硫醇氧化而丧失。通过假设GSTO1在大鼠肝细胞溶胶中催化DMAs(V)和4-NPG的还原,这些不同的发现或许可以得到解释;然而,该酶在还原这些底物时采用了不同的位点和/或机制。